U.S. NIH, 11 drugmakers partner to accelerate cancer therapy research

U.S. NIH, 11 drugmakers partner to accelerate cancer therapy researchThe Trump Administration threw its support behind a public-private partnership with 11 drug companies to advance a new class of drugs that uses the body's immune system to fight cancer. The five-year collaboration is part of the Cancer Moonshot, a program started during the Obama administration and led by former Vice President Joe Biden, whose son Beau died of brain cancer. The Partnership for Accelerating Cancer Therapies or PACT will devote $215 million to identify and test chemical signatures in the body that will help predict which patients will benefit from cancer immunotherapy.